Глава 19
1. Розен В.Б. Основы эндокринологии. М.: Медицина, 1994. С. 197–208.
2. Карева Е.Н., Шимановский Н.Л. Молекулярная фармакология эстрогенов // Молекулярная медицина. 2011. № 1. С. 10–18.
3. Татарчук Т.Ф. Стресс и репродуктивная функция женщины // Междунар. эндокринол. журн. 2006. № 3 (5). С. 2–9.
4. Dennis M.K., Burai R. In vivo effects of a GPR30 antagonist // Nat Chem Biol. 2009. Vol. 1–2, № 214. P. 67–77.
5. Quinn J.A., Graeber C.T. Coordinate regulation of estrogen-mediated fibronectin matrix assembly and epidermal growth factor receptor transactivation by the G protein-coupled receptor, GPR30 // Mol Endocrinol. 2009. Vol. 7, № 23. P. 1052–1064.
6. Heimer G.M., Englund D.E. Effects of vaginally-administered oestriol on post-menopausal urogenital disorders: a cytohormonal study // Maturitas. 1992. Vol. 14. № 3. P. 171–179. doi: 10.1016/0378-5122(92)90112-h.
7. Van Haaften M., Donker G.H., Sie-Go D.M. et al. Biochemical and histological effects of vaginal estriol and estradiol applications on the endometrium, myometrium and vagina of postmenopausal women // Gynecol Endocrinol. 1997. Vol. 11. № 3. P. 175–85. doi: 10.3109/09513599709152532.
8. Бороян Р.Г. Клиническая фармакология для акушеров-гинекологов. М.: Медицинское информационное агентство, 1999. С. 8–123.
9. Mueck A.O., Seeger H., Gräser T. et al. The effects of postmenopausal hormone replacement therapy and oral contraceptives on the endogenous estradiol metabolism // Horm Metab Res. 2001 Dec; 33(12): 744–7. doi: 10.1055/s-2001-19139.
10. Asavasupreechar T., Saito R., Miki Y. et al. Systemic distribution of progesterone receptor subtypes in human tissues // J Steroid Biochem Mol Biol. 2020. № 199: 105599. doi: 10.1016/j.jsbmb.2020.105599. Epub 2020 Jan 25.
11. Сергеев П.В., Шимановский Н.Л. Биохимическая фармакология: учебно-методическое пособие. М.: Мед. информ. агентство, 2010. С. 467–527.
12. Сергеев П.В., Галенко-Ярошевский П.А., Шимановский Н.Л. Очерки биохимической фармакологии. Москва: РЦ «ФАРМЕДИНФО», 1996. C. 280–306.
13. Sleiter N., Pang Y., Park C. et al. Progesterone receptor A (PRA) and PRB-independent effects of progesterone on gonadotropin-releasing hormone release // Endocrinology. 2009. Vol. 150. P. 3833–3844. doi: 10.1210/en.2008-0774.
14. Uhler M.L., Leung A., Chan S.Y., Wang C. Direct effects of progesterone and antiprogesterone on human sperm hyperactivated motility and acrosome reaction // Fertil Steril. 1992. Vol. 58. P. 1191–1198.
15. Karteris E., Zervou S., Pang Y. et al. Progesterone signaling in human myometrium through two novel membrane G protein-coupled receptors: potential role in functional progesterone withdrawal at term // Mol Endocrinol. 2006. № 20. P. 1519–1534. DOI: 10.1210/me.2005-0243.
16. Thomas P., Pang Y. Membrane progesterone receptors: evidence for neuroprotective, neurosteroid signaling and neuroendocrine functions in neuronal cells // Neuroendocrinology. 2012. Vol. 96. P. 162–171. doi: 10.1159/000339822.
17. Palmerini C.A., Mazzoni G., Radicioni V. et al. Antagonistic effect of a salivary proline-rich peptide on the cytosolic Ca2+ mobilization induced by progesterone in oral squamous cancer cells // PLoS One, 2016. Vol. 11. P. e0147925.
18. Albrecht C., Huck V., Wehling M., Wendler A. In vitro inhibition of SKOV-3 cell migration as a distinctive feature of progesterone receptor membrane component type 2 versus type 1 // Steroids, 2012. № 77. P. 1543–1550.
19. Galmozzi A., Kok B.P., Kim A.S., et al. PGRMC2 is an intracellular haem chaperone critical for adipocyte function // Nature. 2019. Vol. 576 (7785). P. 138–142. doi: 10.1038/s41586-019-1774-2.
20. Rodriguez J.A. Interplay between nuclear transport and ubiquitin/SUMO modifications in the regulation of cancer-related proteins // Semin Cancer Biol, 2014. Vol. 27. P. 11–19.
21. Cahill M.A., Jazayeri J.A. Catalano S.M. et al. The emerging role of progesterone receptor membrane component 1 (PGRMC1) in cancer biology // BBA — Reviews on Cancer. 2016, doi: 10.1016/j.bbcan.2016.07.004.
22. Matsumoto R.R., Nguyen L., Kaushal N., Robson M.J. Sigma (σ) receptors as potential therapeutic targets to mitigate psychostimulant effects, in: P.D. Linda (Ed.) Advances in Pharmacology, Vol. 69, Academic Press, 2014, P. 323–386.
23. Keator C.S., Mah K., Slayden O.D. Alterations in progesterone receptor membrane component 2 (PGRMC2) in the endometrium of macaques afflicted with advanced endometriosis // Mol Hum Reprod. 2012. Vol. 18, № 6. P. 308–319. doi: 10.1093/molehr/gas006.
24. Wessel L., Balakrishnan-Renuka A., Henkel C. et al. Long-term incubation with mifepristone (MLTI) increases the spine density in developing Purkinje cells: new insights into progesterone receptor mechanisms // Cell Mol Life Sci, 2014. Vol. 71. P. 1723–1740.
25. Xu G., Wang H., Li W. et al. Leukemia inhibitory factor inhibits the proliferation of gastric cancer by inducing G1-phase arrest // J. Cell. Physiol. 2019. Vol. 234. P. 3613–3620.